Dr. Mohit Saxena : Hematological Oncologists in Gurugram | Narayana Health

Dr. Mohit Saxena

MBBS, MD (General medicine), DM (Medical Oncology) Consultant

  • SpecialityHaemato Oncology, Medical Oncology, Oncology

  • HospitalGurugram - Narayana Superspeciality Hospital, Gurugram


Warning message

The subscription service is currently unavailable. Please try again later.

Narayana Health » Gurugram » Haemato Oncology Medical Oncology Oncology » Dr Mohit Saxena

Brief Profile

Dr. Mohit Saxena after completing his MBBS and MD – General medicine from Sawai Man Singh Medical college and hospital, Jaipur, Rajasthan, thereafter he has been extensively trained in the management of cancer patients at the Prestigious “Gujarat Cancer and Research Institute (GCRI), Ahmedabad” where he did his DM (Medical Oncology) and worked as senior resident (Medical Oncology) before moving to Delhi-NCR.

He worked as consultant, Medical Oncology in Artemis hospital, Gurgaon, Haryana for two and half years. He has vast experience in managing solid tumours and hematological malignancies. He has also worked VPS Rockland hospital, Qutub and Manesar; Paras hospital, Gurgaon and C.K. Birla hospital, Gurgaon and expanded his experience. His last organization was Fortis Flt. Lt. Rajan Dhall hospital, Vasant Kunj, New Delhi where he worked as empaneled consultant.

Currently he is working as Consultant, Medical Oncology and Hematology in Narayana Super Speciality Hospital, Gurgaon.


  • MBBS – Sawai Man Singh Medical Colloege & Hospital, Jaipur, Rajasthan
  • MD (General medicine) – Sawai Man Singh Medical Colloege & Hospital, Jaipur, Rajasthan
  • DM (Medical Oncology) – Gujarat Cancer & Research Institute, Ahmedabad, Gujarat

Post held in past

  • Senior Resident (Medical Oncology) at Gujarat Cancer & Research Institute, Ahmedabad Mar 2016 – Sept 2016
  • Associate Consultant (Medical Oncology) at VPS Rockland Hospital, Qutub & Manesar April 2017 – July 2018
  • Consultant (Medical Oncology) at Artemis Hospital, Gurgaon Nov 2016 – June 2019
  • Consultant (Medical Oncology) at C. K. Birla Hospital, Gurgaon June 2019 - August 2020
  • Consultant (Medical Oncology) at Paras Hospital, Gurgaon July 2019 - Dec 2019
  • Empaneled Consultant (Medical Oncology) at Fortis Hospital, Vasant Kunj, New Delhi Jan 2020 – August 2020

Fields of Experience

  • Chemotherapy {Intravenous, intrathecal, intraperitoneal (HIPEC), Oral metronomic therapy}
  • Targeted therapy and precision medicine
  • Immunotherapy
  • Hormone therapy

Awards & Recognition

  • Faculty in “Oncology, Laser and Eye” in March 2020
  • Participation in “1st Mid year Uro-Oncology update” in August 2019
  • Faculty in the “Management of Cancer Thyroid : Paradigms & Challenges” in 2018
  • Participation in “Innovations in Oncology- Lung cancer edition” in April 2017
  • Participation in “20th National CMI in haematology” in Jan.-Feb. 2015
  • Participation in zonal round of Torrent Young Scholar Award (TYSA) programme in Dec. 2014
  • Training of Good Clinical Practice Workshop in Dec. 2012
  • Merit (9th) in 12TH Board of Secondary Education, Rajasthan in year 1998

Professional Memberships & Certifications

  • American Society of Clinical Oncology (ASCO)


Publication (Original Research):

  • Saxena M, Madabhavi I, Patel A et al. Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre. Int J Hematol Oncol Stem Cell Res 2018 Jul 1; 12(3): 197–203.
  • Saxena M, Panchal H P, Parikh S K et al. High dose Cytarabinearabinoside (Ara-C) as a culprit of leukoencephalopathyin a patient of acute myeloid leukemia. Vidarbha Journal of Internal Medicine 2015 July; 19: 63-66.
  • Saxena M, Rao RS, Sharma BB et al. Primary Anaemia (Haematological Causes): A Prevalence Study in A Tertiary Care Centre. Current Medical Trends 2008; 12:2318-24

Key Procedures Performed

  • Chemotherapy, Targeted therapy, Immunotherapy and Hormone therapy administration
  • Bone marrow aspiration and trephine biopsy
  • Lumber puncture and intrathecal chemotherapy
  • PICC line (Peripherally inserted central catheter) insertion
  • Key Diseases managed:Patients with solid cancers, hematological disorders and malignancies are evaluated and treated. Few of them are as follows – Breast cancer, Lung cancer, Gastrointestinal cancer like colon cancer, Lymphoma, Myeloma, Genitourinary cancer like prostate cancer, bladder cancer, Head and neck cancer, Gynaecological cancer like ovarian, cervical & uterine cancer, Sarcomas, Leukaemia, Blood disorders like anaemia, thrombocytopenia etc.

Rare/ Unique Skills

  • Principal investigator in LAURA study and ADRIATIC study
  • Co-investigator in NEPTUNE study, KESTREL study, HIMALAYA study, MonarchE study, KEYNOTE-593 study etc.

Languages Spoken

Hindi, English